10 research outputs found

    Entrevista a Hèctor Parra

    No full text
    Entrevista a Hèctor Parra, compositor català de música contemporàniaEntrevistadora: Carme Pardo Salgado; Enregistrament i edició de vídeo: Anna Bayó Dura

    Hypermusic Prologue

    No full text
    It is generally accepted that artistic creativity and scientific research share categories, attitudes and values to an extent that goes beyond what one might deduce from their more immediate goals, and also other objectives which are considered characteristic of each of these activities. Beauty, intuition, elegance, the intimate feeling of perfection finally achieved, these are shared cultural values that bring about vivid and very direct communication between scientists and artists who share the same delight in the creation of universes

    Branding monitor

    No full text
    Brand Monitor és una aplicació web que analitza les fonts d'informació d'internet per tal de conèixer la visió que tenen els internautes de la nostra marca comercial. L'eina compta amb persones encarregades d'etiquetar i classificar la informació recolectada, del qual extreurà gràfics i altra informació que posarà a la disposició d'experts que ens aconsellaran

    Branding monitor

    No full text
    Brand Monitor és una aplicació web que analitza les fonts d'informació d'internet per tal de conèixer la visió que tenen els internautes de la nostra marca comercial. L'eina compta amb persones encarregades d'etiquetar i classificar la informació recolectada, del qual extreurà gràfics i altra informació que posarà a la disposició d'experts que ens aconsellaran

    Branding monitor

    No full text
    Brand Monitor és una aplicació web que analitza les fonts d'informació d'internet per tal de conèixer la visió que tenen els internautes de la nostra marca comercial. L'eina compta amb persones encarregades d'etiquetar i classificar la informació recolectada, del qual extreurà gràfics i altra informació que posarà a la disposició d'experts que ens aconsellaran

    A real-time system for measuring sound goodness in instrumental sounds

    No full text
    Comunicació presentada a la 138th Audio Engineering Society Convention, celebrada a Varsòvia (Polònia) els dies 7 a 10 de maig de 2015 i organitzada per la Audio Engineering Society.This paper presents a system that complements the functionality of a typical tuner by evaluating the sound quality of a music performer in real-time. It consists of a software tool that computes a score of how well single notes are played with respect to a collection of reference sounds. To develop such a tool we first record a collection of single notes played by professional performers. Then, the collection is annotated by music teachers in terms of the performance quality of each individual sample. From the recorded samples, several audio features are extracted and a machine learning method is used to find the features that best described performance quality according to musician’s annotations. An evaluation is carried out to assess thecorrelation between systems predictions and musicians criteria. Results show that the system can reasonably predict musicians annotations of performance quality

    A real-time system for measuring sound goodness in instrumental sounds

    No full text
    Comunicació presentada a la 138th Audio Engineering Society Convention, celebrada a Varsòvia (Polònia) els dies 7 a 10 de maig de 2015 i organitzada per la Audio Engineering Society.This paper presents a system that complements the functionality of a typical tuner by evaluating the sound quality of a music performer in real-time. It consists of a software tool that computes a score of how well single notes are played with respect to a collection of reference sounds. To develop such a tool we first record a collection of single notes played by professional performers. Then, the collection is annotated by music teachers in terms of the performance quality of each individual sample. From the recorded samples, several audio features are extracted and a machine learning method is used to find the features that best described performance quality according to musician’s annotations. An evaluation is carried out to assess thecorrelation between systems predictions and musicians criteria. Results show that the system can reasonably predict musicians annotations of performance quality

    Efficacy of A Fluoropyrimidine plus Mitomycin C in Pretreated Patients with Metastatic Colorectal Cancer Eligible for Regorafenib: A Retrospective Study

    No full text
    Objective: In the placebo-controlled CORRECT study, individuals with metastatic colorectal cancer (mCRC) receiving Regorafenib (RGR) achieved significant benefits in both median overall survival (OS: 6.4 months) and progression-free survival (PFS 1.9 months). Patients included in the study had previously failed all standard therapies, which must have included Fluoropyrimidines (FPDs), Oxaliplatin, Irinotecan, Bevacizumab, and Cetuximab or Panitumumab for K-RAS wild-type subjects. FPDs plus Mitomycin C (MMC) represent one of the few treatment options for mCRC patients currently eligible for RGR. We wanted to investigate the therapeutic benefit of this pharmacological association in the same clinical setting defined for RGR. Methods: We retrospectively evaluated the records of mCRC patients followed in our Institutions that would have fulfilled inclusion/exclusion criteria for the CORRECT trial and received instead the combination of FPDs and MMC. We therefore collected data from 87 patients: 61 fulfilled the criteria required for this analysis. Results: Median OS was 9.3 months (95% CI 9.0–15.4), with a median PFS of 3.3 months (95% CI 2.9–3.8). One third of the patients (29.5%) achieved disease control. No significant differences in OS and PFS were found between K-RAS WT and K-RAS mutant individuals. Likewise, Performance Status (PS) and the primary site of disease were not associated with differences in response rates. Conclusions: These results suggest the need for a prospective study assessing RGR cost-effectiveness compared to FPDs plus MMC for mCRC patients that progress after standard treatments

    Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting

    No full text
    corecore